Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Advancing precision medicine: a review of innovative in silico approaches for drug development, clinical pharmacology and personalized healthcare
L Marques, B Costa, M Pereira, A Silva, J Santos… - Pharmaceutics, 2024 - mdpi.com
The landscape of medical treatments is undergoing a transformative shift. Precision
medicine has ushered in a revolutionary era in healthcare by individualizing diagnostics and …
medicine has ushered in a revolutionary era in healthcare by individualizing diagnostics and …
Artificial intelligence and machine learning approaches to facilitate therapeutic drug management and model-informed precision dosing
Background: Therapeutic drug monitoring (TDM) and model-informed precision dosing
(MIPD) have greatly benefitted from computational and mathematical advances over the …
(MIPD) have greatly benefitted from computational and mathematical advances over the …
Artificial intelligence in pharmacology research and practice
In recent years, the use of artificial intelligence (AI) in health care has risen steadily,
including a wide range of applications in the field of pharmacology. AI is now used …
including a wide range of applications in the field of pharmacology. AI is now used …
Bridging the worlds of pharmacometrics and machine learning
Precision medicine requires individualized modeling of disease and drug dynamics, with
machine learning-based computational techniques gaining increasing popularity. The …
machine learning-based computational techniques gaining increasing popularity. The …
Estimation of drug exposure by machine learning based on simulations from published pharmacokinetic models: the example of tacrolimus
We previously demonstrated that Machine learning (ML) algorithms can accurately estimate
drug area under the curve (AUC) of tacrolimus or mycophenolate mofetil (MMF) based on …
drug area under the curve (AUC) of tacrolimus or mycophenolate mofetil (MMF) based on …
A machine learning approach to predict interdose vancomycin exposure
M Bououda, DW Uster, E Sidorov, M Labriffe… - Pharmaceutical …, 2022 - Springer
Introduction Estimation of vancomycin area under the curve (AUC) is challenging in the case
of discontinuous administration. Machine learning approaches are increasingly used and …
of discontinuous administration. Machine learning approaches are increasingly used and …
Machine learning: a new approach for dose individualization
QY Li, BH Tang, YE Wu, BF Yao… - Clinical …, 2024 - Wiley Online Library
The application of machine learning (ML) has shown promising results in precision medicine
due to its exceptional performance in dealing with complex multidimensional data. However …
due to its exceptional performance in dealing with complex multidimensional data. However …
[HTML][HTML] Artificial intelligence, big data and heart transplantation: Actualities
V Palmieri, A Montisci, MT Vietri, PC Colombo… - International Journal of …, 2023 - Elsevier
Background As diagnostic and prognostic models developed by traditional statistics perform
poorly in real-world, artificial intelligence (AI) and Big Data (BD) may improve the supply …
poorly in real-world, artificial intelligence (AI) and Big Data (BD) may improve the supply …
Machine learning algorithms to estimate everolimus exposure trained on simulated and patient pharmacokinetic profiles
Everolimus is an immunosuppressant with a small therapeutic index and large between‐
patient variability. The area under the concentration versus time curve (AUC) is the best …
patient variability. The area under the concentration versus time curve (AUC) is the best …
A hybrid model associating population pharmacokinetics with machine learning: a case study with iohexol clearance estimation
A Destere, P Marquet, CS Gandonnière… - Clinical …, 2022 - Springer
Abstract Background Maximum a posteriori Bayesian estimation (MAP-BE) based on a
limited sampling strategy and a population pharmacokinetic model is frequently used to …
limited sampling strategy and a population pharmacokinetic model is frequently used to …